Patents by Inventor Christopher J. Stanley
Christopher J. Stanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8658374Abstract: Aggregating proteins such as IgG, are bound selectively in the presence of the non-aggregated protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.Type: GrantFiled: July 14, 2011Date of Patent: February 25, 2014Assignee: Microsens Biphage LimitedInventors: Amin Reza Lane, Christopher J. Stanley, Stuart Mark Wilson
-
Patent number: 8460885Abstract: A process for the selective binding of an aggregating abnormal form of a protein in the presence of the nonaggregating normal form of the protein, including contacting under selective binding conditions a material containing both the abnormal and normal forms with a binding agent which is a polyionic material having a binding avidity for the aggregating form of the protein as present in the sample.Type: GrantFiled: December 22, 2009Date of Patent: June 11, 2013Assignee: Microsens Biophage LimitedInventors: Amin Reza Lane, Christopher J. Stanley, Stuart Mark Wilson
-
Publication number: 20120009595Abstract: Aggregating proteins such as IgG, are bound selectively in the presence of the non-aggregated protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.Type: ApplicationFiled: July 14, 2011Publication date: January 12, 2012Applicant: MICROSENS BIOPHAGE LIMITEDInventors: Amin Reza LANE, Christopher J. Stanley, Stuart Mark Wilson
-
Publication number: 20100184054Abstract: A process for the selective binding of an aggregating abnormal form of a protein in the presence of the nonaggregating normal form of the protein, including contacting under selective binding conditions a material containing both the abnormal and normal forms with a binding agent which is a polyionic material having a binding avidity for the aggregating form of the protein as present in the sample.Type: ApplicationFiled: December 22, 2009Publication date: July 22, 2010Applicant: MICROSENS BIOPHAGE LIMITEDInventors: Amin R. Lane, Christopher J. Stanley, Stuart M. Wilson
-
Patent number: 7659076Abstract: Infective aggregating forms of proteins such as PrP, amyloid, and tau are bound selectively in the presence of the normal form protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.Type: GrantFiled: February 28, 2003Date of Patent: February 9, 2010Assignee: Microsens Biophage LimitedInventors: Amin R. Lane, Christopher J. Stanley, Stuart M. Wilson
-
Patent number: 7279311Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridisation affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.Type: GrantFiled: January 17, 2001Date of Patent: October 9, 2007Assignee: Oakville Trading Hong Kong LimitedInventor: Christopher J. Stanley
-
Patent number: 6625479Abstract: An implantable sensor for use in the detection or quantitative measurement of an analyte in subcutaneous fluid, the sensor being biodegradable or hydrolysable in vivo. The sensor incorporates an assay for the analyte, the readout of which is a detectable or measurable optical signal which can, when the sensor is in operation in a subcutaneous location, be interrogated transcutaneously by external optical means.Type: GrantFiled: October 1, 2001Date of Patent: September 23, 2003Assignee: Torsana Diabetes Diagnostics A/SInventors: Anders Weber, Christopher J. Stanley
-
Patent number: 6613527Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: April 15, 2002Date of Patent: September 2, 2003Assignee: Affymetrix, Inc.Inventor: Christopher J. Stanley
-
Patent number: 6395489Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: May 10, 2000Date of Patent: May 28, 2002Assignee: Affymetrix, Inc.Inventor: Christopher J. Stanley
-
Patent number: 6365400Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: June 20, 2000Date of Patent: April 2, 2002Assignee: Affymetrix, Inc.Inventor: Christopher J. Stanley
-
Publication number: 20010004527Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridisation affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.Type: ApplicationFiled: January 17, 2001Publication date: June 21, 2001Applicant: AMDEX A/SInventor: Christopher J. Stanley
-
Patent number: 6207385Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridization affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.Type: GrantFiled: May 18, 1999Date of Patent: March 27, 2001Assignee: Amdex A/SInventor: Christopher J. Stanley
-
Patent number: 6197508Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction. A process is described for annealing complementary strands of nucleic acid by application of an electrical voltage.Type: GrantFiled: July 31, 1998Date of Patent: March 6, 2001Assignee: Affymetrix, Inc.Inventor: Christopher J. Stanley
-
Patent number: 5824477Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: April 1, 1996Date of Patent: October 20, 1998Assignee: Scientific Generics LimitedInventor: Christopher J. Stanley
-
Patent number: 5814450Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process employs a promoter which is an inorganic multivalent cation such as a magnesium ion to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: December 5, 1996Date of Patent: September 29, 1998Assignee: Scientific Generics Ltd.Inventors: Christopher J. Stanley, Patricia L. Archer
-
Patent number: 5607832Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process employs a promoter which is an inorganic multivalent cation such as magnesium ions to speed denaturation. The process may be used in the detection of nucleic acid by hybridrising with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: November 18, 1994Date of Patent: March 4, 1997Assignee: Scientific Generics LimitedInventors: Christopher J. Stanley, Patricia L. Archer
-
Patent number: 5527670Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promotor compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.Type: GrantFiled: August 9, 1994Date of Patent: June 18, 1996Assignee: Scientific Generics LimitedInventor: Christopher J. Stanley
-
Patent number: 5116576Abstract: A device for carrying out an analytical determination which comprises an assay cassette and a transport body which is adapted for location in the assay cassette, the assay cassette having a plurality of discrete reagent chambers which are separated from one another by a separation arrangement which, in use, is ruptured or opened by the transport body. An assay cassette is also described which includes a signal detection chamber that is separated from the final reagent chamber by a separation arrangement which, in use, is ruptured or opened by the transport body.Type: GrantFiled: August 2, 1990Date of Patent: May 26, 1992Assignee: Scientific Generics LimitedInventor: Christopher J. Stanley